Benjamin Trichon, MD
Advanced Heart Failure and Transplant Cardiology · Asheville, NCNPI 1871599860
Payments from drug & device makers
Across 495 payments — averaging $470.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim Pharma GmbH & Co.kg$55K
- United Therapeutics Corporation$42K
- Amgen$37K
- Boehringer Ingelheim International GmbH$34K
- American Regent$28K
- Actelion Pharmaceuticals US, Inc.$18K
- plus $19K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim Pharma GmbH & Co.kg | 13 | $55,403 |
| United Therapeutics Corporation | 23 | $41,954 |
| Amgen | 13 | $36,557 |
| Boehringer Ingelheim International GmbH | 105 | $33,688 |
| American Regent | 17 | $28,329 |
| Actelion Pharmaceuticals US, Inc. | 91 | $17,751 |
| Novartis | 26 | $9,834 |
| Abbott | 109 | $6,862 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $444 |
| Pfizer | 17 | $357 |
| Abiomed | 3 | $314 |
| Merck | 10 | $243 |
| Impulse Dynamics (USA) Inc. | 2 | $197 |
| Cvrx, Inc. | 2 | $147 |
| Alnylam Pharmaceuticals Inc. | 2 | $139 |
| AstraZeneca | 9 | $138 |
| Atricure, Inc. | 6 | $135 |
| E.r. Squibb & Sons, L.L.C. | 6 | $130 |
| Boehringer Ingelheim | 6 | $124 |
| Bayer | 4 | $83 |
| Boston Scientific | 1 | $48 |
| Novo Nordisk | 2 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $23 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
How this compares
$232,983 in reported general payments places this provider in the 70th percentile of 31 advanced heart failure and transplant cardiology providers in North Carolina.
See all advanced heart failure and transplant cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Asheville
- Vinay ThohanAsheville$187K
- Matthew RiesbeckAsheville$13K
- Daniel BensimhonGreensboro$2.5M
- David IshizawarRaleigh$1.2M
- Stephen GreeneDurham$737K
- Dalton McLeanGreensboro$706K
- Emil MissovGreenville$582K
- Hassan AlhosainiWinston Salem$394K
- John RommelWilmington$394K
- Kishan ParikhRaleigh$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.